TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
SLGL

Sol Gel Technologies Ltd

Healthcare · Biotechnology

74.30$ +2.8% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow SLGL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– +33.3% +19.7% +31.2% +61.8% +16.4% +6.7% -7.0% -36.1% -39.1% -31.9% -53.2%
– – -15.7% +317.4% +17.1% -45.2% -52.3% -43.5% +122.3% +21.7% -57.7% -89.6%
– – -31.1% +890.9% -53.3% -43.0% -46.2% -57.0% +113.2% – – –
– – – -428.9% – -143.5% – -856.6% – +116.7% -157.4% –
– +8.6% +32.3% +400.0% -45.4% -43.3% -24.8% -68.2% +19.6% -21.6% -98.5% +2,250.0%
– -123.4% +86.2% +1,418.7% +821.8% – -116.8% – -91.5% -673.4% – -132.1%
– – – – – -86.5% – – – – – –
– +307.0% +47.4% +40.0% – – – – – – – –
– +307.0% +47.4% +40.0% +181.5% -86.5% +149.3% -96.8% -98.2% +145,300.0% -100.0% –
– – -79.1% -278.8% – +527.8% -136.5% – -158.9% – – -166.1%
– – – – – – – – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?